Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ryoko Saito‐Koyama"'
Autor:
Nattaya Duangthim, Thanpisit Lomphithak, Ryoko Saito-Koyama, Yasuhiro Miki, Chihiro Inoue, Ikuro Sato, Eisaku Miyauchi, Jiro Abe, Hironobu Sasano, Siriporn Jitkaew
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-17 (2024)
Abstract Lung cancer remains the leading cause of cancer death. Treatment with immune checkpoint inhibitor (ICI) alone or combination with chemotherapy served as first-line therapy in non-small cell lung cancer (NSCLC). However, only 20–50% of NSCL
Externí odkaz:
https://doaj.org/article/1ce6124ece9c48e5b0eda25e78fa7ddd
Autor:
Sakiko Kumata, Hirotsugu Notsuda, Mei‐Tzu Su, Ryoko Saito‐Koyama, Ryota Tanaka, Yuyo Suzuki, Junichi Funahashi, Shota Endo, Isao Yokota, Toshiyuki Takai, Yoshinori Okada
Publikováno v:
Thoracic Cancer, Vol 14, Iss 21, Pp 2057-2068 (2023)
Abstract Background Leukocyte immunoglobulin‐like receptor subfamily B member 4 (LILRB4/ILT3) is an up‐and‐coming molecule that promotes immune evasion. We have previously reported that LILRB4 facilitates myeloid‐derived suppressor cells (MDS
Externí odkaz:
https://doaj.org/article/e9a541a8876c49a69ded1bfca5584659
Autor:
Chihiro Inoue, Shinya Ohkouchi, Tatsuya Chonan, Atsuko Amata, Takashi Hirama, Ryoko Saito-Koyama, Yoshinori Kawabata, Takashi Suzuki, Yoshinori Okada, Akiyo Tanaka, Hajime Kurosawa
Publikováno v:
Diagnostic Pathology, Vol 18, Iss 1, Pp 1-9 (2023)
Abstract Background Indium lung is characterized by interstitial pneumonia and/or emphysema which occurs in indium-tin oxide (ITO) workers. Indium lung is now known to progress after stopping exposure to ITO, but the long-term influences of ITO remai
Externí odkaz:
https://doaj.org/article/44e63f3d9025498381e4fffbbc4bf089
Autor:
Chihiro Inoue, Sachiko Konosu-Fukaya, Kazuhiro Murakami, Ryoko Saito-Koyama, Hirofumi Watanabe, Hideki Mitomo, Naoya Ishibashi, Takafumi Sugawara, Toshiharu Tabata, Hironobu Sasano, Yasuhiro Nakamura
Publikováno v:
Diagnostic Pathology, Vol 17, Iss 1, Pp 1-9 (2022)
Abstract Background Pulmonary carcinoid tumors rarely coexist with non-small cell lung carcinoma, and only nine cases have been reported previously. The pathogenesis and origin of these combined tumors remain unclear because of its rarity. Case prese
Externí odkaz:
https://doaj.org/article/0c424fec637a4268ae873fdc81d38663
Autor:
Takehiro Yamada, Yasuhiro Miki, Miho Suzuki, Osamu Kondoh, Ryoko Saito‐Koyama, Katsuhiko Ono, Yoshinori Okada, Hironobu Sasano
Publikováno v:
Cancer Medicine, Vol 11, Iss 2, Pp 479-491 (2022)
Abstract Background Programmed cell death ligand 1 (PD‐L1) status has been reported to be different between metastatic and primary lesions in some cases. Therefore, the interaction between carcinoma and immune cells could influence their expression
Externí odkaz:
https://doaj.org/article/8a794d7d86b441d9a01417c384abf3f0
Autor:
Mio Yamaguchi, Tomoaki Sasaki, Kodai Uemura, Yuichiro Tajima, Sho Kato, Kiyoshi Takagi, Yuto Yamazaki, Ryoko Saito-Koyama, Chihiro Inoue, Kurara Kawaguchi, Tomoya Soma, Toshio Miyata, Takashi Suzuki
Publikováno v:
Journal of Pathology Informatics, Vol 13, Iss , Pp 100147- (2022)
Background: A diagnosis with histological classification by pathologists is very important for appropriate treatments to improve the prognosis of patients with breast cancer. However, the number of pathologists is limited, and assisting the pathologi
Externí odkaz:
https://doaj.org/article/eb4e0f6472ee4678b4965963c69226f6
Autor:
Ren Nanamiya, Ryoko Saito-Koyama, Yasuhiro Miki, Chihiro Inoue, Teeranut Asavasupreechar, Jiro Abe, Ikuro Sato, Hironobu Sasano
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 16, p 8522 (2021)
Osimertinib is the latest generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor used for patients with EGFR-mutated non-small cell lung cancer (NSCLC). We aimed to explore the novel mechanisms of osimertinib by particularly foc
Externí odkaz:
https://doaj.org/article/e4959ab783fb4be9bb1c24ebb5c63df9
Autor:
Hirotsugu Notsuda, Hiroki Oshio, Ken Onodera, Takashi Hirama, Yui Watanabe, Tatsuaki Watanabe, Takaya Suzuki, Hisashi Oishi, Hiromichi Niikawa, Ryoko Saito-Koyama, Masafumi Noda, Junya Tominaga, Yoshinori Okada
Publikováno v:
Tohoku Journal of Experimental Medicine; May2024, Vol. 263 Issue 1, p35-42, 8p
Autor:
Daniel-Costin Marinescu, Ganesh Raghu, Martine Remy-Jardin, William D. Travis, Ayodeji Adegunsoye, Mary Beth Beasley, Jonathan H. Chung, Andrew Churg, Vincent Cottin, Ryoko Egashira, Evans R. Fernández Pérez, Yoshikazu Inoue, Kerri A. Johannson, Ella A. Kazerooni, Yet H. Khor, David A. Lynch, Nestor L. Müller, Jeffrey L. Myers, Andrew G. Nicholson, Sujeet Rajan, Ryoko Saito-Koyama, Lauren Troy, Simon L.F. Walsh, Athol U. Wells, Marlies S. Wijsenbeek, Joanne L. Wright, Christopher J. Ryerson
Publikováno v:
Chest. 162(3):614-629
Recent clinical practice guidelines have addressed the diagnosis of idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (fHP). These disease-specific guidelines were developed independently, without clear direction on how to
Autor:
Keitaro Fujii, Shinkichi Morita, Mai Mochizuki, Rie Shibuya‐Takahashi, Haruna Fujimori, Kazunori Yamaguchi, Jiro Abe, Tomoko Yamazaki, Takayuki Imai, Kazuo Sugamura, Jun Yasuda, Kennichi Satoh, Ikuro Sato, Ryoko Saito‐Koyama, Fumiyoshi Fujishima, Hironobu Sasano, Yukinari Kato, Kazuto Matsuura, Yukinori Asada, Keiichi Tamai
Publikováno v:
Cancer Science. 113:2878-2887
Various proteins are highly expressed in cancer (e.g., epidermal growth factor receptor); however, the majority are also expressed in normal cells, although they may differ in expression intensity. Recently, we reported that CD271 (nerve growth facto